Macleods Pharmaceuticals Limited ... Products' (ISIC: 2100). This industry belongs to the broader 'Pharmaceuticals' (ISIC: 21) sector. Companies in the basic pharmaceutical product manufacturing ...
This recall is initiated as a precautionary measure due to potential migration of Benzophenone at very low level into product from ... manufactured by Macleods Pharmaceuticals Ltd at its Baddi ...
Explore listed products List your instruments Listings of Structured Products can be done with one days’ notice. Once an approved issuer, the review of the instrument application process is fast.
Alexion Pharmaceuticals, Inc. is a biopharmaceutical ... development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma.
View all information regarding the medicines that are manufactured by Glaxo Smithkline Pharmaceuticals Ltd. including its generic drug name, trade name, how to use, the price, and its composition.
India's drug regulator, the Central Drugs Standards Control Organisation (CDSCO), has listed more than 50 drugs as "Not of ...
Emcure Pharmaceuticals Limited ... Botanical Products' (ISIC: 2100). This industry belongs to the broader 'Pharmaceuticals' (ISIC: 21) sector. Companies in the basic pharmaceutical product ...
A recall notice was issued for 60,000 Wawa-branded beverage tumblers after four injuries were reported from the products’ metal straws. The U.S. Food and Drug Administration says the E.
Manufacture and commercially distribute its prescription pharmaceutical SCENESSE in the European Union and the USA for the treatment of the rare, genetic metabolic disorder EPP, research and ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...